WO42312 - GDC-9545 IN ER+ve HER2-VE LOCALLY ADVANCED OR METASTATIC BREAST CANCER

• Research type

  Research Study

• Full title

  A PHASE II, RANDOMIZED, OPEN-LABEL, MULTICENTER STUDY EVALUATING THE EFFICACY AND SAFETY OF GDC-9545 COMPARED WITH PHYSICIAN'S CHOICE OF ENDOCRINE MONOTHERAPY IN PATIENTS WITH PREVIOUSLY TREATED ESTROGEN RECEPTOR-POSITIVE, HER2-NEGATIVE LOCALLY ADVANCED OR METASTATIC BREAST CANCER

• IRAS ID

  1003413

• Contact name

  Sarah Khan

• Contact email

  sarah.khan@nuh.nhs.uk

• Eudract number

  2020-001984-10

• Clinicaltrials.gov Identifier

  NCT04576455

• REC name

  East of Scotland Research Ethics Service REC 2

• REC reference

  20/ES/0094

• Date of REC Opinion

  11 Nov 2020

• REC opinion

  Further Information Favourable Opinion